AU5231186A - Amino-salicylic acid derivatives salts thereof process for their preparation and pharmaceutical compositions containing them - Google Patents

Amino-salicylic acid derivatives salts thereof process for their preparation and pharmaceutical compositions containing them

Info

Publication number
AU5231186A
AU5231186A AU52311/86A AU5231186A AU5231186A AU 5231186 A AU5231186 A AU 5231186A AU 52311/86 A AU52311/86 A AU 52311/86A AU 5231186 A AU5231186 A AU 5231186A AU 5231186 A AU5231186 A AU 5231186A
Authority
AU
Australia
Prior art keywords
amino
preparation
pharmaceutical compositions
compositions containing
acid derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52311/86A
Other languages
English (en)
Inventor
Sportoletti Ciancarlo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Italfarmaco SpA
Original Assignee
Italfarmaco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco SpA filed Critical Italfarmaco SpA
Publication of AU5231186A publication Critical patent/AU5231186A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56Amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Saccharide Compounds (AREA)
AU52311/86A 1984-11-29 1985-11-26 Amino-salicylic acid derivatives salts thereof process for their preparation and pharmaceutical compositions containing them Abandoned AU5231186A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT23799A/84 1984-11-29
IT23799/84A IT1196348B (it) 1984-11-29 1984-11-29 Composti ad attivita'antiinfiammatoria

Publications (1)

Publication Number Publication Date
AU5231186A true AU5231186A (en) 1986-06-18

Family

ID=11210091

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52311/86A Abandoned AU5231186A (en) 1984-11-29 1985-11-26 Amino-salicylic acid derivatives salts thereof process for their preparation and pharmaceutical compositions containing them

Country Status (12)

Country Link
EP (1) EP0236329A1 (enrdf_load_stackoverflow)
JP (1) JPS62501703A (enrdf_load_stackoverflow)
KR (1) KR870700608A (enrdf_load_stackoverflow)
CN (1) CN85109554A (enrdf_load_stackoverflow)
AU (1) AU5231186A (enrdf_load_stackoverflow)
DK (1) DK346486D0 (enrdf_load_stackoverflow)
ES (1) ES8701717A1 (enrdf_load_stackoverflow)
GR (1) GR852834B (enrdf_load_stackoverflow)
IT (1) IT1196348B (enrdf_load_stackoverflow)
PT (1) PT81566B (enrdf_load_stackoverflow)
WO (1) WO1986003199A1 (enrdf_load_stackoverflow)
ZA (1) ZA859035B (enrdf_load_stackoverflow)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9017711D0 (en) * 1990-08-13 1990-09-26 May & Baker Ltd New compositions of matter
GB9017710D0 (en) * 1990-08-13 1990-09-26 May & Baker Ltd New compositions of matter
IT1244873B (it) * 1990-09-12 1994-09-12 Depha Team Srl Derivati dell'acido 5-aminosalicilico (5-asa) per la terapia delle infiammazioni croniche intestinali
US5366987A (en) * 1991-08-22 1994-11-22 Warner-Lambert Company Isoxazolyl-substituted alkyl amide ACAT inhibitors
FR2738150B1 (fr) * 1995-09-01 1997-10-31 Synthelabo Utilisation de la sulphasalazine et de ses metabolites pour la fabrication d'un medicament utile dans le traitement de l'insuffisance veineuse et des ulceres veineux
ES2226818T3 (es) * 2000-04-19 2005-04-01 Neurotech Co., Ltd. Compuestos, composiciones y metodos para prevenir la neurodegeneracion y daños cronicos en el sistema nervioso central.
US6964982B2 (en) 2000-04-20 2005-11-15 Neurotech Co., Ltd. Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
NO20013534L (no) * 2000-07-18 2002-01-21 Koyo Chemical Company Ltd Anvendelse av en blanding omfattende et glucosaminsalt eller et glucosaminderivat for fremstilling av et medikament for behandling av human trombose
DE60141725D1 (de) 2001-01-19 2010-05-12 Apex Biotechnology Corp Nicht enzymatischer Einwegerkennungselektrodenstreifen der einen oberflächenaktiven Stoff beinhaltet, zum Nachweis von Harnsäure; Herstellungsverfahren dafür und Verwendung davon
KR20040048411A (ko) 2001-09-14 2004-06-09 메틸진, 인크. 히스톤 데아세틸라아제의 억제제
AU2003245070C1 (en) 2002-06-19 2008-02-28 GNT Pharma Co., Ltd Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
KR100668111B1 (ko) 2005-07-28 2007-01-12 (주)에스에이치제약 강력한 항산화 효과를 가짐으로써 급성 및 퇴행성 뇌신경계질환의 예방 및 치료에 이용 가능한 신규물질인아미노살리실산 유도체와 그 염의 제조방법
AU2007239191B2 (en) 2006-04-13 2010-10-28 Neurotech Pharmaceuticals Co., Ltd. Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases
CN100422721C (zh) * 2006-05-26 2008-10-01 南京大学 一种利用糖基萘酚的铝离子检测方法
KR20100097113A (ko) * 2007-10-23 2010-09-02 가부시키가이샤 이야쿠 분지 셋케이 겐쿠쇼 Pai-1 생산 억제제
KR100852962B1 (ko) 2007-11-12 2008-08-20 주식회사 뉴로테크 2-하이드록시-5-페닐알킬아미노벤조산 유도체 및 이의 염의제조방법
SG192488A1 (en) * 2008-07-08 2013-08-30 Catabasis Pharmaceuticals Inc Fatty acid acetylated salicylates and their uses
US9085527B2 (en) 2008-07-08 2015-07-21 Catabasis Pharmaceuticals, Inc. Fatty acid acylated salicylates and their uses
KR101204108B1 (ko) * 2009-02-09 2012-11-22 주식회사 지엔티파마 5-벤질아미노살리실산 유도체 또는 이의 염의 의약 용도
NZ599067A (en) 2009-09-01 2014-04-30 Catabasis Pharmaceuticals Inc Fatty acid niacin conjugates and their uses
USRE46608E1 (en) 2009-09-01 2017-11-14 Catabasis Pharmaceuticals, Inc. Fatty acid niacin conjugates and their uses
JP6202287B2 (ja) * 2012-05-23 2017-09-27 セリックスビオ プライヴェート リミテッド 炎症性腸疾患の治療のための組成物及び方法
WO2014070859A1 (en) * 2012-10-30 2014-05-08 H. Lee Moffitt Cancer Center And Research Institute, Inc. Stat3 dimerization inhibitors
KR20210107828A (ko) * 2018-12-28 2021-09-01 주식회사 지엔티파마 신경퇴행성 질환 치료를 위한 조성물 및 방법
CN111116395B (zh) * 2019-12-27 2023-04-07 湖北工业大学 多碘代芳香酸类化合物及其在抗腺病毒7型中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4546M (enrdf_load_stackoverflow) * 1964-06-09 1966-11-02
NL7008623A (enrdf_load_stackoverflow) * 1969-06-25 1970-12-29
JPS5640710B2 (enrdf_load_stackoverflow) * 1973-01-18 1981-09-22
JPS6056130B2 (ja) * 1978-03-20 1985-12-09 久光製薬株式会社 新規なサリチル酸誘導体
US4536346A (en) * 1983-05-06 1985-08-20 American Cyanamid Company Aralkanamidophenyl compounds

Also Published As

Publication number Publication date
IT8423799A0 (it) 1984-11-29
DK346486A (da) 1986-07-21
GR852834B (enrdf_load_stackoverflow) 1986-03-27
DK346486D0 (da) 1986-07-21
EP0236329A1 (en) 1987-09-16
ES8701717A1 (es) 1986-12-01
ZA859035B (en) 1986-08-27
PT81566B (en) 1987-04-07
KR870700608A (ko) 1987-12-30
JPS62501703A (ja) 1987-07-09
CN85109554A (zh) 1986-07-23
ES549359A0 (es) 1986-12-01
PT81566A (en) 1985-12-01
WO1986003199A1 (en) 1986-06-05
IT1196348B (it) 1988-11-16

Similar Documents

Publication Publication Date Title
AU5231186A (en) Amino-salicylic acid derivatives salts thereof process for their preparation and pharmaceutical compositions containing them
PT86366A (en) Process for the preparation of phosphinic acid derivatives and of pharmaceutical compositions containing the same
IL76453A (en) Isoxazolecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
HUT43825A (en) Process for producing quinolon-carboxylic acid derivatives and pharmaceutical compositions containing them
HUT48902A (en) Process for producing new ribofuranuronic acid derivatives and pharmaceutical compositions containing them
IL74826A (en) 3-cephem-4-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
PH20703A (en) Quinolinecarboxylic acid derivatives process for their preparation and pharmaceutical composition containing them
HUT40639A (en) Process for producing quinolon-carboxylic acid derivative and pharmaceutical composition containing them
PT83565A (en) Process for the preparation of acid aryl-heterocyclic-alcoxi-acetic derivatives and of pharmaceutical compositions containing same
IL77849A0 (en) Aryldihydropyridinedicarboxylic acid ester derivatives,their preparation and pharmaceutical compositions containing them
AU537560B2 (en) Phenyl-alkanoic acid derivatives and their preparation and pharmaceutical compositions containing them
HUT41801A (en) Process for producing new cepheme-carboxylic acid derivatives and pharmaceutical compositions containing them
HU895952D0 (en) Process for the preparation of substituted pyrrolidone-2-carboxylic acid derivatives and pharmaceutical compositions containing them
IL75603A0 (en) 1,3-dioxanylheptenoic acid derivatives,their preparation and pharmaceutical compositions containing them
IL75913A0 (en) Phenyl-nonatetraenoic acid derivatives,their preparation and pharmaceutical compositions containing them
SG59992G (en) Dihydroorotic acid derivatives,processes for their preparing and pharmaceutical composition containing them
ZA864504B (en) Derivatives of 2-fluoroalkylbenzimidazole,process for their preparation and pharmaceutical compositions containing them
IL80679A (en) 16,17-acetalsubstituted pregnane 21-oic acid derivatives,process for their preparation and pharmaceutical compositions containing them
PT80799B (en) Aminoeburnanecarboxylic acid derivatives pharmaceutical compositions containing them and process for preparing same
AU578104B2 (en) Pharmaceutical composition of peroxydiphosphoric acid derivatives
DE3661070D1 (en) 2-(substituted sulfamyl) derivatives of 6-nitrobenzoic acid, process for their preparation and pharmaceutical compositions containing them
PT80800A (en) Nitroapovincaminic acid derivatives pharmaceutical compositions containing them and process for preparing same
IL77799A0 (en) Dihydropyridinedicarboxylic acid ester derivatives,their preparation and pharmaceutical compositions containing them
IL89836A0 (en) Penicilanic acid derivatives,process for their preparation and pharmaceutical compositions containing them
IL69105A0 (en) Apovincaminic acid derivatives,process for their preparation and pharmaceutical compositions containing them